These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 28450168)
1. Tuning complement activation and pathway through controlled molecular architecture of dextran chains in nanoparticle corona. Coty JB; Eleamen Oliveira E; Vauthier C Int J Pharm; 2017 Nov; 532(2):769-778. PubMed ID: 28450168 [TBL] [Abstract][Full Text] [Related]
2. Complement activation by core-shell poly(isobutylcyanoacrylate)-polysaccharide nanoparticles: influences of surface morphology, length, and type of polysaccharide. Bertholon I; Vauthier C; Labarre D Pharm Res; 2006 Jun; 23(6):1313-23. PubMed ID: 16715369 [TBL] [Abstract][Full Text] [Related]
3. Formation of Protein Corona on Nanoparticle Affects Different Complement Activation Pathways Mediated by C1q. Ding T; Sun J Pharm Res; 2019 Dec; 37(1):10. PubMed ID: 31872347 [TBL] [Abstract][Full Text] [Related]
4. Immunoglobulin deposition on biomolecule corona determines complement opsonization efficiency of preclinical and clinical nanoparticles. Vu VP; Gifford GB; Chen F; Benasutti H; Wang G; Groman EV; Scheinman R; Saba L; Moghimi SM; Simberg D Nat Nanotechnol; 2019 Mar; 14(3):260-268. PubMed ID: 30643271 [TBL] [Abstract][Full Text] [Related]
5. Complement proteins bind to nanoparticle protein corona and undergo dynamic exchange in vivo. Chen F; Wang G; Griffin JI; Brenneman B; Banda NK; Holers VM; Backos DS; Wu L; Moghimi SM; Simberg D Nat Nanotechnol; 2017 May; 12(4):387-393. PubMed ID: 27992410 [TBL] [Abstract][Full Text] [Related]
6. Complement activation in vitro and reactogenicity of low-molecular weight dextran-coated SPIONs in the pig CARPA model: Correlation with physicochemical features and clinical information. Fülöp T; Nemes R; Mészáros T; Urbanics R; Kok RJ; Jackman JA; Cho NJ; Storm G; Szebeni J J Control Release; 2018 Jan; 270():268-274. PubMed ID: 29203414 [TBL] [Abstract][Full Text] [Related]
7. Mechanistic understanding of in vivo protein corona formation on polymeric nanoparticles and impact on pharmacokinetics. Bertrand N; Grenier P; Mahmoudi M; Lima EM; Appel EA; Dormont F; Lim JM; Karnik R; Langer R; Farokhzad OC Nat Commun; 2017 Oct; 8(1):777. PubMed ID: 28974673 [TBL] [Abstract][Full Text] [Related]
8. Mechanisms of complement activation by dextran-coated superparamagnetic iron oxide (SPIO) nanoworms in mouse versus human serum. Banda NK; Mehta G; Chao Y; Wang G; Inturi S; Fossati-Jimack L; Botto M; Wu L; Moghimi SM; Simberg D Part Fibre Toxicol; 2014 Nov; 11():64. PubMed ID: 25425420 [TBL] [Abstract][Full Text] [Related]
9. Characterization of fluorescent poly(isobutylcyanoacrylate) nanoparticles obtained by copolymerization of a fluorescent probe during Redox Radical Emulsion Polymerization (RREP). Zandanel C; Vauthier C Eur J Pharm Biopharm; 2012 Sep; 82(1):66-75. PubMed ID: 22634238 [TBL] [Abstract][Full Text] [Related]
10. Configuration of bovine serum albumin adsorbed on polymer particles with grafted dextran corona. Vauthier C; Lindner P; Cabane B Colloids Surf B Biointerfaces; 2009 Mar; 69(2):207-15. PubMed ID: 19135340 [TBL] [Abstract][Full Text] [Related]
11. Modulatory Role of Surface Coating of Superparamagnetic Iron Oxide Nanoworms in Complement Opsonization and Leukocyte Uptake. Inturi S; Wang G; Chen F; Banda NK; Holers VM; Wu L; Moghimi SM; Simberg D ACS Nano; 2015 Nov; 9(11):10758-68. PubMed ID: 26488074 [TBL] [Abstract][Full Text] [Related]
12. Modulation of complement activation and amplification on nanoparticle surfaces by glycopolymer conformation and chemistry. Yu K; Lai BF; Foley JH; Krisinger MJ; Conway EM; Kizhakkedathu JN ACS Nano; 2014 Aug; 8(8):7687-703. PubMed ID: 25106451 [TBL] [Abstract][Full Text] [Related]
13. Enrichment of immunoregulatory proteins in the biomolecular corona of nanoparticles within human respiratory tract lining fluid. Kumar A; Bicer EM; Morgan AB; Pfeffer PE; Monopoli M; Dawson KA; Eriksson J; Edwards K; Lynham S; Arno M; Behndig AF; Blomberg A; Somers G; Hassall D; Dailey LA; Forbes B; Mudway IS Nanomedicine; 2016 May; 12(4):1033-1043. PubMed ID: 26767511 [TBL] [Abstract][Full Text] [Related]
14. Interactions of nanoparticles bearing heparin or dextran covalently bound to poly(methyl methacrylate) with the complement system. Passirani C; Barratt G; Devissaguet JP; Labarre D Life Sci; 1998; 62(8):775-85. PubMed ID: 9489513 [TBL] [Abstract][Full Text] [Related]
15. Enhancing the tolerance of poly(isobutylcyanoacrylate) nanoparticles with a modular surface design. Chauvierre C; Leclerc L; Labarre D; Appel M; Marden MC; Couvreur P; Vauthier C Int J Pharm; 2007 Jun; 338(1-2):327-32. PubMed ID: 17324536 [TBL] [Abstract][Full Text] [Related]
16. Understanding the Chemical Nature of Nanoparticle-Protein Interactions. Baimanov D; Cai R; Chen C Bioconjug Chem; 2019 Jul; 30(7):1923-1937. PubMed ID: 31259537 [TBL] [Abstract][Full Text] [Related]
17. Person-Specific Biomolecular Coronas Modulate Nanoparticle Interactions with Immune Cells in Human Blood. Ju Y; Kelly HG; Dagley LF; Reynaldi A; Schlub TE; Spall SK; Bell CA; Cui J; Mitchell AJ; Lin Z; Wheatley AK; Thurecht KJ; Davenport MP; Webb AI; Caruso F; Kent SJ ACS Nano; 2020 Nov; 14(11):15723-15737. PubMed ID: 33112593 [TBL] [Abstract][Full Text] [Related]
18. Intentional formation of a protein corona on nanoparticles: Serum concentration affects protein corona mass, surface charge, and nanoparticle-cell interaction. Gräfe C; Weidner A; Lühe MV; Bergemann C; Schacher FH; Clement JH; Dutz S Int J Biochem Cell Biol; 2016 Jun; 75():196-202. PubMed ID: 26556312 [TBL] [Abstract][Full Text] [Related]
19. Interactions of blood proteins with poly(isobutylcyanoacrylate) nanoparticles decorated with a polysaccharidic brush. Labarre D; Vauthier C; Chauvierre C; Petri B; Müller R; Chehimi MM Biomaterials; 2005 Aug; 26(24):5075-84. PubMed ID: 15769543 [TBL] [Abstract][Full Text] [Related]
20. Quantitative Analysis of Protein Corona on Precoated Protein Nanoparticles and Determined Nanoparticles with Ultralow Protein Corona and Efficient Targeting in Vivo. Zhong Z; Fang S; Li Y; Huang Y; Zhang Y; Chen H; Zhang J; Wang HX; Xiong H; Zou Q; Wang S ACS Appl Mater Interfaces; 2021 Dec; 13(48):56812-56824. PubMed ID: 34817983 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]